미국의 COVID-19 팬데믹 완화 제품(COVID-19 의약품 시장, COVID-19 백신 시장, 개인보호구(PPE), Self-collection용 스왑, COVID-19용 인공지능(AI), 원격 방사선 진단, 안구 보호구 등) 시장(-2024년)
U.S. COVID-19 Pandemic Mitigation Products (COVID-19 Drugs Market, COVID-19 Vaccine Market, PPE, Self-collection Swabs, COVID-19 AI, Personal Protection Gear, Teleradiology, Eye Protection, and More) Market to 2024
상품코드 : 955012
리서치사 : Homeland Security Research Corporation (HSRC)
발행일 : 2020년 08월
페이지 정보 : 영문 450 Pages; 250 Tables & Figures
US $ 4,950 ₩ 6,322,000
PDF (Single User License)
US $ 5,950 ₩ 7,599,000
PDF (Departmental License)
US $ 8,950 ₩ 11,430,000
PDF (Site License)
US $ 12,000 ₩ 15,326,000
PDF (Corporate License)


한글목차

미국의 코로나19(COVID-19) 팬데믹 완화 제품 시장 규모는 2020-2024년 누계 5,100억 달러에 이를 전망입니다(연도 및 예측 시나리오에 근거).

2020년 3월까지 미국 의회는 전례 없는 2조 2,000억 달러 상당의 최초의 COVID-19 구호 패키지를 승인했습니다. 다만, 감염 상황과 대응 상황은 주에 따라 크게 다를 뿐만 아니라, 연방정부의 대응이 늦은 적도 있어서 감염자수/사망자수는 여전히 높은 수준입니다.

미국의 COVID-19 팬데믹 완화 제품 시장을 분석했으며, 전체 시장 규모(처치 건수) 동향 전망, 주요 제품/서비스별·최종사용자별 상세 동향, 시나리오별 예측, 업계 관계자가 향후 해결해야 할 과제 등의 정보를 정리하여 전해드립니다.

본 보고서의 예측 시나리오

A. 본 보고서의 분석 내용

B. 주요 제품 및 서비스별 분석(총 29개 항목)

최종사용자 시장별 분석(총 6개 항목)

수익원별 분석(총 4개)

C. 시장 부문별 분석 : 분석 프레임워크 상세

D. 주요 기업의 최신 동향과 시장 데이터(총 37개사)

E. COVID-19 팬데믹 완화 커뮤니티 정보원(합계 2,300개 이상)

F. 본문에서 언급된 벤더(총 450개사 이상)

G. 부록

LSH 20.11.06
영문 목차

영문목차

Title:
U.S. COVID-19 Pandemic Mitigation Products
(COVID-19 Drugs Market, COVID-19 Vaccine Market, PPE, Self-collection Swabs, COVID-19 AI, Personal Protection Gear, Teleradiology, Eye Protection, CT, X-Ray, Ultrasound, COVID-19 IT, Telemedicine, PACS, Face Shields, PPE Gowns, Coronavirus Homecare, Mechanical Ventilators, Gloves, E-Health, Robotic PCR Market, Point of Care Antigen Test, PCR Reagents, Face Masks, ICU, Contact Tracing, Sterilization Systems, Point of Care Serologic Test, Polymerase Chain Reaction, Test Kits, Surge Hospitals and More) Market to 2024 .

On the backdrop of the need for essential medical products and services, a new market has emerged, the COVID-19 pandemic mitigation products market . This US COVID-19 pandemic mitigation cumulative 2020-2024 market is worth $510 Billion (scenario B).

(*) Market size is year and scenario dependent.

To adhere to our high standards of research, as nobody can forecast the future of the pandemic, we include in the report two scenarios:

Why trust this report?

Bottom Line: while other COVID-19 reports are written (at best) by MBAs, this report is published by seasoned professionals for experts

By 2019, U.S. healthcare spending stood at $3.3 trillion, more than 42% of global healthcare expenditures.

By March 2020 Congress approved an unprecedented $2.2 trillion COVID-19 first relief package. It includes $161 Billion to the VA, CDC, FDA, Medicare, the Strategic National Stockpile and COVID-19 Vaccines. It does not cover the monthly deficit of $50 Billion that the Hospitals Managers Association reported.

USA has one of the biggest regional inequalities. Big towns on the East Coast were hit hard by COVID-19 in March and April, other American states imposed a locked down policy fast enough to curtail outbreaks. The rate of coronavirus deaths per 100,000 people in the U.S. is lower than in several European countries.

Having said that, by July America suffered from a coronavirus second wave. In several states it took a month to update death certificates, which means that the initial numbers they publish for a given time are considerable undercounts, leading to the false sense of deaths.

According to the report, despite the huge size of the U.S. Healthcare sector, the U.S. became the global leading COVID-19 victim - why?

The USA is and will continue to be the largest COVID-19 mitigation products market because that is the only option it has, and it has unlimited resources to invest whatever it takes to mitigate the pandemic.

The U.S.'s COVID-19 pandemic mitigation products market drivers are:

The USA COVID-19 pandemic mitigation products market is driven by the demand for the following:

and the following factors:

This 450 -page market report is the most comprehensive review of the American COVID-19 market available today. The objective of this report is to provide today's strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market.

The US COVID-19 Pandemic Mitigation Products Market - 2020-2024 report presents a thorough market analysis of 29 products & services, 6 end user and 4 revenue source markets. Furthermore , the report provides updated extensive data of 37 key vendors.

Why Buy this US COVID-19 Pandemic Mitigation Products Market Report?

A. Questions answered in this report include:

B. American COVID-19 market size data is analyzed via 5 independent key perspectives. With a highly fragmented market we address the "money trail" - each dollar spent in the US COVID-19 market is analyzed and crosschecked via 3 orthogonal viewpoints:

By 29 Products and Services:

By 6 End User Markets:

By 4 Revenue Source Markets:

C. Detailed market analysis frameworks for each of the market sectors are provided, including:

E. The report includes over 2300 links to the COVID-19 pandemic mitigation community information sources

F. The report mentions > 450 Vendors including the following:

Moderna, IBM, 3M Company, Philips NV, Johnson & Johnson, Roche, Nvidia Corporation, Thermo Fisher Scientific, Siemens, Toshiba, Google, Samsung Electronics Co, GE Healthcare, Medtronic, MedWhat, MedyMatch, Merck, Metabiota, Micron Technology, Infermedica, Infervision, Inovio Pharmaceuticals, Microsoft Corporation, Mindshare Medical, Morpheo, Pfizer, Philips NV, Maxim Biotech, Honeywell Safety Products, Philips Healthcare, Siemens, Recursion Pharmaceuticals, Fujifilm Holdings Corporation, 3Scan, Abbott , AbCellera, Advenio Technosys, Agfa Healthcare, Agilent Technologies, AiCure, Aindra, Allscripts Healthcare Solutions, Amara Health Analytics, Amazon , analyticsMD, Apixio, Apple, Arterys Inc., Atlas Wearables, Atomwise, Avalon Nutrition VITL, Babylon Health, Bay Labs, Behold.ai, benevolent.ai, BIOBEATS, BlueDot, Bollé Safety, Bullard, Buoy Health, Care Angel Wearables QorQL, Careskore, Clinithink, Cloud Pharmaceuticals, CloudMedx, CureMetrix Mental health Ginger.io, Cyrcadia, Deep 6 AI, Deep Genomics, Dell Technologies Inc., Delta Plus Group, Desktop Genetics Virtual mate Ada Health, DreaMed Diabetes, Dupont, EaglEyeMed, Eli Lilly, Encon Safety Products, Enlitic, EnsoData, Entopsis, Envisagenics Research iCarbonX, ERB Industries Inc., Ergodyne, Essilor of America, Flashback Technologies, Flow Health, Ford, Freenome, Frequency Therapeutics Inc., Gateway Safety Inc., General Motors, General Vision, Gentex Corporation, Gibco, Gilead Sciences, Globavir Biosciences, Healint, Health Fidelity, HealthNextGen, HexArmor, Hindsait, Imagen Technologies, Imagia Cybernetics, Inside DNA, InSilico Medicine, Intel Corporation, Intendu, Invitrogen, Ion Torrent, Ironwear, Jvion, Kapa Biosystems, Keen Eye Technologies, Kimberly-Clark Professional, Lexmark International Inc., LifeGraph, Lucina Health, Lumiata, Lunit, Lytics, Magnea, Maxwell MRI, McKesson Corporation, MCR Safety, Medal, Medalogix, Medasense, MedAware, Niramai Health Analytix, Novarad Corporation, NuMedii, Numerate, Nuritas Pharma Turbine, Oncora Medical, Ovuline, PeerWell, PhysIQ, Precision Health Intelligence, Predible Health, Profility, Proscia, pulseData, Pyramex Safety, Qualaris Healthcare Solutions, Qualcomm Incorporated, Qualcomm Incorporated, Qure.Ai, Radians Inc., Roam Analytics, RxPREDICT, Safety Optical Service Ltd, Sanofi, Saykara, Sellstrom Manufacturing Company (SureWerx), Sense.ly, Sensory Inc., Sigma-Aldrich Corp., Skymind Inc., Vir Biotechnology Inc., VisionAid Inc., WuXi Biologics, Xilinx Inc. and more.

G. US COVID-19 market report includes 5 appendices:

COVID-19 pandemic mitigation market research team

The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen identification, E-health, decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, ultrasound, electron microscopy, medical devices and more. Our team members bring long term relations with the U.S. FDA and CDC as well as the EU CE and other national medical regulatory agencies.

As early as January 20, 2020 we recruited all our analysts to research the COVID-19 pandemic mitigation related products purchases. We interviewed hundreds of experts, participated in more than 95 conferences and webinars, reviewed more than 1,500 publications and interviewed executives of more than 65 pandemic related companies.

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기